Measurement of postheparin plasma diamine oxidase (PHD) 
3.7-7.7 U/ml). In 35 patients with active disease (Crohn's disease activity index (CDAI) > 150) two groups were identified by choosing a cut off value of 2 U/ml: 93% of the 15 patients with PHD values lower than 2 U/mi (mean (SD) 1*36 (0.46) U/ml) relapsed at least once in the following year, while only the 20% of the 20 whose values were higher than 2 U/mi (mean (SD) (1.50)) relapsed in the same period.
The data were statistically significant (Yates's corrected x2=15-63; p<0.0001). The positive and negative predictive values of the test were 93% and 80%, respectively. During relapses, PHD values were consistently lower than previous values, and increased significantly after effective medical or surgical treatment. In the six patients in whom there were no changes in disease activity (CDAI persistently <150), there was no change in PHD values. This test may be useful for identifying Crohn's disease patients who are likely to relapse. Furthermore, the data indicate that mucosal damage is common in active small bowel Crohn's disease and improves at least in part after treatment. 6 
CHANGES IN PHD VALUES AFTER TREATMENT
To verify the effectiveness of treatment in the recovery of small bowel mucosal integrity, the test was repeated in 23 patients with active disease two to three months after clinical improvement (CDAI <150) resulting from medical treatment. In six patients who subsequently underwent intestinal resection, the PHD value was assessed before and six months after surgery.
PHD TEST AND DAO ASSAY
Heparin (15 000 IU) was administered by intravenous bolus. Blood (7 ml) was drawn 60 minutes after the injection, collected in heparinised tubes, and centrifuged at 3000 g. The plasma was stored at -200C and assayed for DAO within a week. To simplify the test, plasma DAO activity was assessed only in the blood sample taken 60 minutes after heparin injection instead ofin the several samples necessary for the calculation of the area under a 0-120 minute curve, as described in our previous study.7 In fact, the 60 minute sample correlates very well with the corresponding area under the curve and is the best discriminator among patients with different intestinal diseases.'7 DAO was assayed in triplicate by a '4C-putrescine method as described in a previous study. 17 DAO activity was expressed as U/ml (1 U= 1 nmol of putrescine dihydrochloride oxidised for 1 hour at 37°C, pH 7'2). The normal range (44 subjects) is 3-7-7-7 U/mI; mean (2SD)=5-3 (2) U/ml.
In each patient, liver function (prothrombin time, alanine aminotransferase, bilirubin, alkaline phosphatase) was tested to avoid the possibility of impaired liver uptake of In all subjects partial thromboplastin time (PTT) was monitored. Three hours after the beginning of the test, PTT was still 2-2 5 times the maximum value of the normal range (22-44 seconds). It returned to normal within five hours of heparin injection.
Whenever the test was performed as an outpatient procedure, patients were allowed to leave the hospital four hours afterwards.
STATISTICAL ANALYSIS
Differences in PHD values before and after treatment were evaluated by Student's t test for paired data. Differences in outcomes of patients and the relative risk of relapse in the two groups of patients were assessed by the x2 test using the EPIINFO version 5 (Public Domain Software for Epidemiology and Disease Surveillance). Results are expressed as mean (SD) and differences were considered statistically significant when p<0 05.
Results
PHD values recorded in the active phase of the disease in patients who relapsed during the one year follow up and in those who did not were 2-1 (1 8) and 3 3 (1X2) U/ml respectively. Choosing a PHD cut off value of 2 U/ml we identified two groups of patients; 14 out of 15 patients (group A) whose PHD values were lower than 2-0 (1X36 (0-46) U/ml) during the active phase of the disease relapsed at least once in the following year, while only four of the 20 patients (group B) with PHD values above 2-0 (3-69 (1-5) U/ml) relapsed during follow up (Table) . The mean PHD values of the A and B groups of patients were significantly different (p<0 001).
The average treatment time required for clinical recovery ranged from one to three months and was not different in the two groups studied.
Using (1 5) No of patients 15 20
No of relapsed patients/year 14 4 Group whom the test was repeated after remission induced by anti-inflammatory treatment. Values before and after treatment were 2-30 (1 33) and 4-44 (1-62) U/ml, respectively (Fig 1) .
Five patients underwent resection because of complications (three had intestinal obstruction, one abdominal abscess, and one ileocolonic fistula). One additional patient whose disease remitted after medical treatment, needed to be operated on for intestinal obstruction 12 months later. Figure 2 shows the PHD values in these six patients before and six months after surgery. A significant (p<0-001) increase in PHD was observed in all patients.
Six patients whose disease was not active when admitted to our department did not relapse over a mean (SD) 
